Detalhe da pesquisa
1.
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.
Proc Natl Acad Sci U S A
; 117(22): 12288-12294, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430334
2.
Effects of gamma frequency binaural beats on attention and anxiety.
Curr Psychol
; : 1-8, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37359672
3.
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 23(8): 1055-1065, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803286
4.
Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
N Engl J Med
; 375(22): 2165-2176, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959755
5.
Successful newborn screening for SCID in the Navajo Nation.
Clin Immunol
; 158(1): 29-34, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762520
6.
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
J Allergy Clin Immunol
; 132(1): 140-50, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810098
7.
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
JAMA
; 312(7): 729-38, 2014 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25138334
8.
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial.
Clin Lymphoma Myeloma Leuk
; 24(4): 240-253, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195322
9.
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study.
J Clin Oncol
; : JCO2302329, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547425
10.
Newborn screening for SCID identifies patients with ataxia telangiectasia.
J Clin Immunol
; 33(3): 540-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23264026
11.
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv
; 7(17): 4926-4935, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067952
12.
TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma.
JCO Clin Cancer Inform
; 6: e2100121, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044836
13.
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.
J Clin Oncol
; 40(5): 481-491, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914545
14.
Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection.
J Clin Invest
; 118(5): 1835-45, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18398508
15.
History and current status of newborn screening for severe combined immunodeficiency.
Semin Perinatol
; 39(3): 194-205, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937517
16.
Viral bioinformatics: computational views of host and pathogen.
Novartis Found Symp
; 254: 234-47; discussion 247-52, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14712941
17.
Transcriptional instability during evolving sepsis may limit biomarker based risk stratification.
PLoS One
; 8(3): e60501, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23544148
18.
Oxidative phosphorylation gene expression falls at onset and throughout the development of meningococcal sepsis-induced multi-organ failure in children.
Intensive Care Med
; 41(8): 1489-90, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25920543
19.
Dendritic cells in viral pathogenesis: protective or defective?
Int J Exp Pathol
; 86(4): 187-204, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16045541
20.
Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion.
J Immunol
; 173(6): 4108-19, 2004 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15356161